Multiple sclerosis tag sponsored by:
Multiple sclerosis
-
A randomized, double-blind, double-dummy, parallel-group study, comparing the efficacy and safety of remibrutinib versus teriflunomide in participants with relapsing multiple sclerosis, followed by extended treatment with open-label remibrutinib. |
onderzoekmetmensen.nl | | Article Details | Related Articles